Document is current

Any future updates will be listed below

In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models

Crossref DOI link: https://doi.org/10.1136/jitc-2021-002432

Published Online: 2021-05-28

Published Print: 2021-05

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark